Patent 9445944 was granted and assigned to Mati Therapeutics on September, 2016 by the United States Patent and Trademark Office.
Lacrimal implants for treating diseases or disorders are disclosed. More particularly, lacrimal implants, methods of making such implants, and methods of treating ocular, respiration, inner ear or other diseases or disorders using such implants are disclosed.